Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on May 28, 2021 2:49pm
58 Views
Post# 33287661

RE:RE:RE:RE:RE:Insiders

RE:RE:RE:RE:RE:InsidersNot short interest but volume, if half of the shares during trading sessions are shorted yet the monthly short interest is going down then one has to wonder whether there is an element of daily manipulation going on.
Having said that I fully agree the low demand is main cause of the depressed  SP. So again the company needs to attract more investors who are willing to stay invested for a medium to long term returns.  
canadapiet wrote:

scarlet1967 - (5/28/2021 1:08:13 PM) 
RE:RE:RE:Insiders

The short interest for THTX was 316k in mid April versus 260k in mid May so not 40% lower but it is the lowest short interest in months.



For me, short intrest has nothing to do with this shi..y  share price! There may? be? a kind? of manipulation?......., but that will only come from the buyers of that other shi..y offering! 

And we have suddenly volume.......but why are we down????

Th is a mystery! 
 


<< Previous
Bullboard Posts
Next >>